Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Therion Biologics and NCI initiate phase II trial of novel melanoma vaccines

Oct. 19, 1999

Ariad discloses a wide series of cellular signal transduction inhibitors

Oct. 18, 1999

The Liposome Company to resubmit its NDA for Evacet

Oct. 15, 1999

Inhibitors of tumor cell proliferation patented by Roche

Oct. 15, 1999

NuChem's anticancer drug candidates to be featured at upcoming oncology meeting

Oct. 14, 1999

Disappointing results reported from phase III lisofylline trial

Oct. 14, 1999

Vion to commence phase I trial of VNP-20009

Oct. 14, 1999

ImClone Systems initiates enrollment in phase II C225/CPT-11 trial

Oct. 13, 1999

SU-5416: promising phase I findings presented at ICAAC; update on clinical status

Oct. 13, 1999

Nonpeptide modulators of GnRH release patented by Alanex

Oct. 13, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...